How to Help Your Patients Find Evista in Stock: A Provider's Guide

Patients who are prescribed Evista (raloxifene) for postmenopausal osteoporosis or breast cancer risk reduction are increasingly reaching out to their providers when they can't get their prescriptions filled. While raloxifene is not in a formal FDA shortage as of 2026, localized pharmacy gaps create real barriers — and as the prescribing provider, you have several tools at your disposal to help.

Why Patients Struggle to Find Evista

When a patient says "I can't find my medication," there are typically a few root causes worth investigating:

Their pharmacy only stocks brand, not generic (or vice versa). This is the most common and most easily resolved barrier. Updating the prescription to allow DAW-0 substitution or explicitly prescribing generic raloxifene resolves this in most cases.

Their pharmacy has temporarily run out. A special order can often resolve this within 1–3 business days. Educate patients to ask for a special order rather than simply accepting "we don't have it."

They're trying to fill at an independent or rural pharmacy. Large chains like CVS, Walgreens, Walmart, and Costco typically stock generic raloxifene more reliably than small independents.

Insurance is denying coverage. This is a separate issue from supply availability. If coverage is the barrier, see our section below on cost-saving strategies.

Prescribing Strategies to Reduce Fill Barriers

A few simple prescribing choices can dramatically reduce the chance a patient encounters an access barrier:

Prescribe "raloxifene 60 mg tablets" generically, not brand Evista. Multiple manufacturers produce the generic, making it more broadly available.

Write for 90-day supplies whenever possible. Mail-order pharmacies routinely fill 90-day supplies and rarely encounter stock issues with raloxifene.

Consider e-prescribing directly to a mail-order pharmacy for patients who've had repeated fill issues. Most insurance plans offer a mail-order option through Express Scripts, OptumRx, or CVS Caremark.

Call ahead for high-risk patients. For patients for whom a medication gap would be particularly concerning, have your staff call the patient's pharmacy before sending the prescription to confirm stock.

How to Use medfinder for Your Patients

One of the most effective things you can do for a patient struggling to find raloxifene is to direct them to medfinder. medfinder calls pharmacies near the patient to check which ones can fill a specific prescription, then texts the patient the results. This eliminates the frustrating phone loop and helps patients locate available stock efficiently.

You can share the medfinder website with patients directly during office visits, or include it in your after-visit summary for patients on raloxifene. It covers all medications — not just those in shortage.

Patient Counseling Talking Points

Equip your patients with the right language when they contact their pharmacy:

"Do you have raloxifene hydrochloride 60 mg tablets in stock? If not, can you order it? When would it arrive?"

"My doctor says I can use the generic version — do you have raloxifene if you don't have Evista?"

"Can I transfer my prescription to a different location that has it in stock?"

When to Consider a Medication Change

If a patient has made multiple genuine attempts to find raloxifene and access remains a consistent problem, a clinical switch may be warranted. The main considerations:

For osteoporosis: alendronate, risedronate, denosumab, or zoledronic acid are evidence-based options with AACE support.

For breast cancer risk reduction in postmenopausal women: tamoxifen 20 mg daily is FDA-approved, but the uterine cancer risk is higher than with raloxifene. Review benefits vs. risks individually.

Document the access barrier in your chart note for clinical and administrative purposes.

Documentation Recommendations

When a patient reports inability to access their medication, document: the pharmacy contacted, the date of reported stock issue, and the clinical action taken (special order request, pharmacy transfer, alternative prescription). For more on the clinical background, see our Evista shortage overview for providers.